Movement Is Medicine: The 217-Trial BMJ Study That Names the Best Exercise for Knee Osteoarthritis
A landmark BMJ network meta-analysis of 217 randomized trials and 15,684 participants delivers the clearest evidence yet: aerobic exercise is the most effective first-line treatment for knee osteoarthritis, outperforming strength training, mind-body practices, and mixed programs for pain relief and long-term function.
If you have knee osteoarthritis, or know someone who does, you have almost certainly heard the circular logic that keeps millions of people sedentary: my knees hurt, so I can’t exercise. The new science, published April 30, 2026, in the British Medical Journal, demolishes that logic with the most comprehensive evidence ever assembled on the topic.
The study, a network meta-analysis led by researchers at institutions across China and Switzerland, reviewed 217 randomized controlled trials conducted between 1990 and 2024, enrolling a combined 15,684 participants. The verdict was decisive: aerobic exercise, specifically walking, cycling, and swimming, is the most beneficial exercise modality for managing knee osteoarthritis, improving pain, physical function, gait performance, and quality of life, with moderate to high certainty across multiple time horizons.
This is not a minor study. This is the kind of evidence that should reshape clinical conversations, physical therapy protocols, and public health messaging about one of the most prevalent and debilitating conditions on the planet.
The Scale of the Problem
Knee osteoarthritis is among the most common causes of chronic pain and disability worldwide. According to a comprehensive Global Burden of Disease analysis published in PLOS One, there were an estimated 374.7 million knee osteoarthritis cases globally in 2021, with an annual incidence of more than 3 million new cases and 12.01 million disability-adjusted life years lost each year. Projections published in the Journal of Orthopaedic Surgery and Research suggest the global prevalence will increase by 43.8 percent by 2035, driven by aging populations, rising obesity rates, and sedentary lifestyles.
Despite the availability of effective non-pharmacological treatments, most patients are still managed primarily through pain medications, including non-steroidal anti-inflammatory drugs and, eventually, joint replacement surgery. Exercise is routinely recommended but rarely prescribed with the specificity and confidence the science now warrants. That gap between evidence and practice is precisely what the BMJ study addresses.
What the Research Team Did
The international research team, led by Lei Yan, Dijun Li, Bin Wang, and colleagues, used a network meta-analysis design, a statistical method that allows simultaneous comparison of multiple interventions even when they have not been tested head-to-head in the same trial. This approach is considered the gold standard for ranking competing therapies when a large body of evidence exists across different study populations and settings.
They included 217 randomized controlled trials spanning 35 years of research, covering six major exercise categories: aerobic exercise, flexibility training, strengthening programs, mind-body practices such as tai chi and yoga, neuromotor training, and mixed or combined exercise programs. Each category was evaluated against control conditions for four key outcomes: pain reduction, physical function improvement, gait performance, and quality of life, measured at short-term (up to 3 months), mid-term (3 to 12 months), and long-term (beyond 12 months) follow-up intervals.
To rank treatments, the team calculated surface under the cumulative ranking curve (SUCRA) values, a statistical measure where a higher score indicates a higher probability of being the best treatment. Aerobic exercise posted a mean SUCRA value of 0.72 across all outcomes, the highest of any modality tested.
What Aerobic Exercise Actually Accomplished
The results were consistent and clinically meaningful across every time point studied. Aerobic exercise produced large improvements in pain relief at both short-term and mid-term follow-up. It improved physical function at short-term, mid-term, and long-term follow-up, making it the only category to demonstrate sustained functional benefit across all three measurement windows. It enhanced gait performance and quality of life in both the short and mid-term.
Crucially, none of the exercise types studied were linked to a higher risk of adverse events compared with control conditions. This directly addresses one of the most persistent fears among patients and clinicians alike: that exercise will accelerate joint damage or worsen pain. The evidence says the opposite. Exercise is not only effective; it is safe.
Mind-body exercise, which includes tai chi, yoga, and qigong, demonstrated the highest probability of being best for short-term function and gait, which makes it a valuable complementary tool, particularly for patients who cannot tolerate sustained cardiovascular loading. Neuromotor training also showed promise for short-term gait improvement. Strengthening programs delivered meaningful benefits for mid-term function. But across the full range of outcomes and time horizons, aerobic exercise was the most consistently effective and durable intervention.
The Biology Behind Why It Works
The superiority of aerobic exercise is not arbitrary. A growing body of mechanistic research explains precisely why sustained, rhythmic movement is uniquely therapeutic for arthritic joints.
Cartilage in the knee joint is avascular, meaning it has no direct blood supply. It receives nutrients and clears metabolic waste through the mechanical pumping action of compression and decompression during movement. When joints are loaded cyclically, as they are during walking, cycling, or swimming, synovial fluid circulates through cartilage tissue, delivering oxygen and glucose while removing inflammatory byproducts. Sedentary joints, by contrast, become nutritionally deprived and biochemically hostile to cartilage health.
Featured Partner
Invest in the Infrastructure Behind Modern Medicine
As healthcare expands beyond hospital walls, the buildings and campuses supporting that shift are generating compelling returns for investors who move early. The Healthcare Real Estate Fund offers qualified investors direct access to a curated portfolio of medical office, outpatient, and specialty care facilities.
Learn More →Beyond nutrition, aerobic exercise drives a powerful anti-inflammatory shift in joint biology. Research published in Frontiers in Physiology has shown that sustained aerobic activity upregulates the expression of anti-inflammatory cytokines, including interleukin-10, interleukin-4, TGF-beta, and IGF-1, while simultaneously downregulating the pro-inflammatory signals, including IL-1-beta, IL-6, and TNF-alpha, that drive cartilage degradation in osteoarthritis. These are the same inflammatory cascades that pharmaceutical interventions attempt to suppress with drugs, and aerobic exercise modulates them without the side effect profile of chronic NSAID use.
Exercise also stimulates Type B synoviocytes, specialized cells lining the joint capsule, to produce lubricin and hyaluronic acid, the molecular lubricants that reduce friction and protect cartilage surface integrity. A 2025 review in Frontiers in Physiology confirmed that regular aerobic exercise stands out as the most effective non-surgical strategy for preserving synovial joint health at the molecular level.
There is also the weight management dimension. Each pound of excess body weight adds approximately four to six pounds of compressive force to the knee joint during walking. Aerobic exercise, as the primary caloric expenditure modality, directly reduces mechanical joint loading through body composition improvement, which compounds the biochemical and lubrication benefits described above.
A Closer Look at the Top Three Modalities
Within the aerobic exercise category, the BMJ analysis and related network meta-analyses point to walking, cycling, and swimming as the three modalities with the strongest evidence base and the best safety profiles.
Walking is the most accessible and the most extensively studied. The I-Min Lee lab at Harvard and the Paluch JAMA Internal Medicine cohort studies have documented clear dose-response relationships between daily steps and joint health outcomes. Even modest increases from sedentary baselines to 4,000 to 5,000 daily steps produce measurable improvements in knee pain and function. The post-meal walk deserves special mention: brief 10 to 15 minute walks after eating not only blunt blood glucose spikes (which drive systemic inflammation) but also promote lymphatic drainage and synovial fluid circulation in lower extremity joints.
Cycling, whether on a stationary bike or outdoors, offers the advantage of joint-friendly loading. Because the bike supports body weight, the compressive forces on the knee are lower than during walking, making cycling the preferred starting point for individuals with severe pain or high BMI. The circular, continuous range of motion also provides excellent synovial fluid distribution throughout the joint capsule.
Swimming and water-based aerobic exercise provide buoyancy that substantially reduces joint load while still delivering the cardiovascular and anti-inflammatory benefits of sustained aerobic work. Aquatic therapy has strong evidence for reducing pain in individuals who cannot tolerate land-based exercise due to severity, weight, or co-existing conditions.
Why Exercise Is Still Under-Prescribed
Given the strength of the evidence, the persistent under-prescription of exercise as a first-line therapy for knee osteoarthritis represents one of the most actionable gaps in modern healthcare. Several structural barriers explain the gap.
Clinical appointment times rarely allow for the kind of exercise counseling that produces behavioral change. Physical therapy referrals, when they happen, often focus on strengthening protocols derived from older evidence rather than the aerobic-first approach the new BMJ analysis supports. And patients, particularly older adults who grew up with the message that worn-out joints need rest, need explicit reassurance that movement is protective, not destructive.
There is also an industry dynamic worth noting. Aerobic exercise has no patent, no manufacturer, and no marketing budget. Anti-inflammatory drugs, joint injections, and surgical interventions do. The result is a healthcare system structurally inclined toward pharmacological and procedural management of a condition that the largest evidence review ever conducted says responds best to walking.
A 2025 comparative efficacy review published in PubMed (PMID 41093618) found that exercise consistently outperformed minimal or passive control conditions across every osteoarthritis outcome measured, with moderate to large effect sizes. The authors called for a fundamental reorientation of osteoarthritis management guidelines to center exercise as a primary, not adjunctive, therapy.
Integrating Exercise Into an Osteoarthritis Management Plan
The BMJ analysis does not position aerobic exercise as a replacement for other modalities. Mind-body practices, strengthening exercises, and flexibility work all showed meaningful benefits and are best used in combination with an aerobic foundation. The research framework that emerges is one of hierarchy rather than exclusivity: aerobic exercise as the primary anchor, supplemented by strengthening and mind-body work based on individual tolerance and goals.
The researchers specifically recommended aerobic exercise as a first-line intervention when the clinical aim is to improve functional capacity and reduce pain, noting that other exercise types are best used alongside aerobic activity rather than replacing it.
For healthcare providers, this finding argues for incorporating structured aerobic exercise prescriptions, including specific modality, duration, frequency, and progression guidelines, into standard osteoarthritis management protocols. For individuals managing knee pain, it argues for prioritizing daily movement as aggressively as any other therapeutic intervention, including medication.
The Longevity Connection
Knee osteoarthritis is not just a pain problem. It is a longevity problem. The Global Burden of Disease data shows that knee OA accounts for more than 12 million disability-adjusted life years annually, and its downstream effects extend far beyond joint function. People who reduce their physical activity due to knee pain experience accelerated muscle loss (sarcopenia), cardiovascular deconditioning, metabolic dysfunction, and cognitive decline. The joint is the gateway: lose mobility, and the entire physiological cascade of active aging begins to unravel.
This makes the BMJ finding doubly important from a longevity science perspective. Aerobic exercise does not just treat the symptom (knee pain). It preserves the fundamental capacity for physical activity that anchors healthspan. Maintaining the ability to walk, cycle, or swim into the seventh and eighth decades of life is among the most powerful predictors of all-cause mortality and quality of life that the epidemiological literature has identified.
The VO2 max literature is instructive here. Cardiorespiratory fitness, best measured as maximal oxygen uptake, is the single strongest predictor of longevity across multiple large cohort studies. Aerobic exercise is the primary driver of VO2 max. Knee osteoarthritis, left unmanaged through sedentary coping, progressively erodes the capacity for aerobic activity and, with it, the protective fitness reserve that determines how long and how well people live.
What This Means for You
If you have been diagnosed with knee osteoarthritis, or if you experience regular knee pain during daily activities, the evidence from this 217-trial BMJ analysis translates into a clear, actionable framework:
Start with walking. Even 15 to 20 minutes daily, at a brisk but comfortable pace, is enough to begin producing the anti-inflammatory and synovial fluid benefits that make aerobic exercise therapeutic rather than harmful. If pain is severe, begin in water, where buoyancy reduces joint load, or on a stationary bike, where the seated position offloads body weight. The goal is not to push through pain but to maintain consistent, gentle motion that signals to the joint’s biology that it is still being used and needs to remain functional.
Progress gradually. The research supports increasing duration and frequency over weeks and months as pain tolerance improves. A physical therapist familiar with exercise-based OA management can help design a progression protocol suited to your specific pain pattern, joint stability, and fitness level.
Do not wait for pain to resolve before moving. The evidence is clear that movement is part of the treatment, not something to start after treatment works. Waiting for a pain-free baseline before beginning exercise is a path to progressive deconditioning that makes both the pain and the biology worse.
Add mind-body and strengthening work as supplements, not substitutes. Tai chi, in particular, showed impressive results for gait improvement and falls prevention in the BMJ analysis. The quadriceps and hip abductors, strengthened through targeted resistance work, act as dynamic shock absorbers for the knee joint. A well-rounded program combines all three elements with aerobic exercise as the foundation.
Finally, recognize that the stakes extend beyond your knees. Maintaining aerobic capacity through osteoarthritis is a direct investment in cardiovascular health, metabolic resilience, cognitive function, and the longevity reserve that every active year of life builds. The joint that moves stays healthier than the joint that rests, and so does everything connected to it.
Sources: Yan L, et al. “Comparative efficacy and safety of exercise modalities in knee osteoarthritis: systematic review and network meta-analysis.” BMJ, April 30, 2026. Global Burden of Disease Study 2021 (PLOS One, Journal of Orthopaedic Surgery and Research). Frontiers in Physiology, “Clinical effect and mechanism of aerobic exercise for knee osteoarthritis: a mini review,” 2025. PubMed PMID 41093618, comparative efficacy review 2026.
